pocketful logo light
pocketful logo light
Anthem Biosciences Ltd logo

Anthem Biosciences Ltd

NSE: ANTHEM BSE: 544449

₹769.10

(1.46%)

Tue, 26 May 2026, 05:44 pm

mtf coin illustrationMTF 5x

Anthem Biosciences Share Price Live Chart

1 Day

(1.46%)

No Result Found

Summary

  • Market Cap

    43078.79

  • Net Profit

    451.26

  • P/B

    0

  • Sector P/E

    34.11

  • P/E

    0

  • EV/EBITDA

    0

  • Debt/Equity (Industry)

    0.29

  • Interest Cover (Industry)

    4.50

  • ROCE (Industry)

    9.39

  • RONW (Industry)

    7.26

  • ROE

    20.82

  • ROCE

    28.24

  • Debt/Equity

    0.08

  • EPS (TTM)

    10.81

  • Dividend Yield

    0

  • Book Value

    54.03

  • Interest Cover

    63.38

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025DEC 2024
Promoters74.6874.6974.6977.23
FII1.281.361.670
DII11.557.607.220
Public12.5016.3516.4222.77
Government0000

Read More

Technical Analysis

RSI

53.19

MACD

12.53

50 DMA

723.74

200 DMA

713.72

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1006.72869.07814.58731.42676.93593.77456.12
Fibonacci869.07816.48784.00731.42678.83646.35593.77
Camarilla797.95785.34772.72731.42747.48734.86722.25

Pivots Level: Classic

R3

+275.30

1006.72

R2

+137.65

869.07

R1

+83.17

814.58

731.42
731.42
Pivot Point
LTP: 772.25

S1

-54.48

676.93

S2

-137.65

593.77

S3

-275.30

456.12

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    777.76

  • 20-EMA

    771.81

  • 30-EMA

    760.39

  • 50-EMA

    739.77

  • 100-EMA

    718.94

  • 200-EMA

    718.53

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
19 May 2026dividend₹2.00 Dividend /Share26 Jun 2026
19 May 2026board-meetingsAccounts, Final Dividend
19 May 2026agm
05 Feb 2026board-meetingsQuarterly Results
08 Nov 2025board-meetingsQuarterly Results

Read More

Peer Comparison

Anthem Biosciences Ltd logo

Anthem Biosciences Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Read More

Anthem Biosciences Ltd About

Anthem Biosciences are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilities across drug discovery, development, and commercial manufacturing. We provide end to end CRDMO services and we serve a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2006

Headquarters

CEO

Ajay Bhardwaj

Employees

Contact

Website icon

Website

http://www.anthembio.com

Email icon

Email

investors.abl@anthembio.com

Phone icon

Phone

+91 080 6672 4000

Location icon

Location

49 F1 & F2 Canara Bank Road, Bommasandra Industrial Area, Bangalore, Karnataka, 560099

Read More

Anthem Biosciences Ltd Company History

YearHistory
2020
  • Commenced operations in biological facility 2 earmarked for a specific client.
2022
  • Expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL.
2023
  • Received the first USFDA audit approval and first therapeutic goods administration audit for Unit II.
  • Addition of Oligonucleotide lab in Unit I.
  • Set a cGMP scale continuous flow manufacturing facility for Unit II.
2024
  • Received the second USFDA audit approval for Unit II.
  • Received the first ANVISA audit approval for Unit I.
  • Received the first ANVISA audit approval for Unit II.
  • Commenced operations of Neoanthem Lifesciences Private Limited, at Unit III.
  • Fermentation capacity expanded to 140 KL at Unit II.
  • Conversion of our Company into a public limited company, under the name Anthem Biosciences Limited.
2025
  • Received the fourth USFDA approval for Unit I.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
VIRIDITY TONE LLPbulkSell20313795621.1109 Mar 2026
HDFC MUTUAL FUNDbulkBuy6075000621.109 Mar 2026
SBI MUTUAL FUNDbulkBuy3226020621.109 Mar 2026

Read More

Anthem Biosciences Ltd News

Anthem Biosciences to attend investor meets

Anthem Biosciences will attend Nomura and Citi conferences in June 2026. No UPSI will be discussed.

22 May 2026

companies

Anthem Biosciences posts Q4FY26 earnings call

Anthem Biosciences has released the audio recording of its Q4 and FY26 earnings call held on May 20, 2026. The recording covers audited standalone and consolidated results.

20 May 2026

companies

Anthem Biosciences Schedules Q4 FY26 Earnings Call

Anthem Biosciences has scheduled its Q4 & FY2026 earnings conference call for May 20, 2026, at 11:00 AM IST, to discuss audited standalone and consolidated financial results.

12 May 2026

companies

Anthem Biosciences Board Meet on May 19 for FY26 Results

Anthem Biosciences schedules Board meeting on May 19, 2026 to approve audited standalone and consolidated financial results for Q4 and FY26, and consider final dividend.

12 May 2026

companies

Anthem Biosciences appoints new auditors, approves upside sharing

Anthem Biosciences Board appoints M/s. S. R. Batliboi & Associates LLP as statutory auditors for 5 years from FY2026-27 to FY2031-32. Board also approves upside sharing arrangement with Viridity Tone LLP involving INR 1,276.83 million payment to promoters.

22 Apr 2026

companies

Read More